Murata T - Search Results

1

Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis.

Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. Tohgi H, et al. Among authors: murata t. Ann Neurol. 1999 Jul;46(1):129-31. doi: 10.1002/1531-8249(199907)46:1<129::aid-ana21>3.0.co;2-y. Ann Neurol. 1999. PMID: 10401792

2

Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis.

Murata T, Ohtsuka C, Terayama Y. Murata T, et al. Free Radic Res. 2008 Mar;42(3):221-5. doi: 10.1080/10715760701877262. Free Radic Res. 2008. PMID: 18344116

3

Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.

Murata T, Ohtsuka C, Terayama Y. Murata T, et al. J Neurol Sci. 2008 Apr 15;267(1-2):66-9. doi: 10.1016/j.jns.2007.09.038. Epub 2007 Oct 24. J Neurol Sci. 2008. PMID: 17961597

4

Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.

Isobe C, Murata T, Sato C, Terayama Y. Isobe C, et al. Among authors: murata t. J Clin Neurosci. 2007 Apr;14(4):340-3. doi: 10.1016/j.jocn.2005.12.023. Epub 2006 May 2. J Clin Neurosci. 2007. PMID: 16647853

5

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.

Isobe C, Murata T, Sato C, Terayama Y. Isobe C, et al. Among authors: murata t. Life Sci. 2005 Aug 26;77(15):1836-43. doi: 10.1016/j.lfs.2005.02.014. Life Sci. 2005. PMID: 15935398

6

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.

Abe T, Tohgi H, Isobe C, Murata T, Sato C. Abe T, et al. Among authors: murata t. J Neurosci Res. 2002 Nov 1;70(3):447-50. doi: 10.1002/jnr.10349. J Neurosci Res. 2002. PMID: 12391605

7

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease.

Abe T, Isobe C, Murata T, Sato C, Tohgi H. Abe T, et al. Among authors: murata t. Neurosci Lett. 2003 Jan 16;336(2):105-8. doi: 10.1016/s0304-3940(02)01259-4. Neurosci Lett. 2003. PMID: 12499051 Clinical Trial.

8

Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease.

Isobe C, Abe T, Kikuchi T, Murata T, Sato C, Terayama Y. Isobe C, et al. Among authors: murata t. Eur J Neurol. 2006 Apr;13(4):346-50. doi: 10.1111/j.1468-1331.2006.01207.x. Eur J Neurol. 2006. PMID: 16643311

9

Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

Abe T, Tohgi H, Murata T, Isobe C, Sato C. Abe T, et al. Among authors: murata t. Neurosci Lett. 2001 Oct 26;312(3):177-9. doi: 10.1016/s0304-3940(01)02214-5. Neurosci Lett. 2001. PMID: 11602339

10

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. Tohgi H, et al. Among authors: murata t. Neurosci Lett. 1999 Jul 2;269(1):52-4. doi: 10.1016/s0304-3940(99)00406-1. Neurosci Lett. 1999. PMID: 10821643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results